Global Hunter Securities has initiated coverage on Cubist Pharmaceuticals CBST with a Neutral rating and no price target.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: InitiationAnalyst RatingsBiotechnologycubist pharmaceuticalsGlobal Hunter SecuritiesHealth Care
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in